Last edition
News about "Trial for Alexander Disease"
Ionis Experimental Drug Zilganersen Shows Promise in Trial for Alexander Disease
Ionis Pharmaceuticals has reported positive topline results from a pivotal study of its experimental drug zilganersen in patients with Alexander disease, a rare, progressive and often fatal neurological disorder.
Trial For Alexander Disease | 23/09/2025 | By Darshana | 194
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members